This session addresses the complexities of lymphadenectomy in salvage esophagectomy for recurrent or persistent esophageal cancer. Dr. T.S. Rao discusses the technical and clinical challenges associated with prior treatments such as chemoradiotherapy, highlighting the importance of specialized, high-volume centers. Key topics include complication management, preservation of critical structures such as bronchial arteries, and operative strategies in high-risk settings.

The session concludes with an expert Q&A moderated by Dr. Caleb Harris, covering extent of dissection, recurrent laryngeal nerve management, thoracic duct preservation, and the use of imaging such as FDG PET-CT in guiding lymphadenectomy.


You may also like

Follow Up after Curative Treatment for Esophageal Cancer – Sheraz Markar
ISDE Members Only
2views
0likes
Listen to Dr. Sheraz Markar present during the Adenocarcinoma Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, including: Neoadjuvant Treatment for ...
Should All Patients with Proven Reflux and Symptoms on PPI Have an Operation? - Sarah Thompson
ISDE Members Only
4views
0likes
Listen to Dr. Sarah Thompson present during the Challenges in the Diagnosis and Management of GERD Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, ...
Achalasia: From Diagnosis to Treatment to Surveillance
ISDE Members Only
8views
0likes
The session covers achalasia, focusing on its epidemiology, misdiagnosis, and advancements in diagnosis and treatment. It highlights the importance of endoscopy and the Car Scoring System for accurate diagnosis. Various assessment techniques and ...
Late Breaking Oral Abstracts: Clinical Trials in Esophageal Cancer
ISDE Members Only
5views
0likes
Clinical trials in esophageal cancer reveal that robotic surgery outperforms traditional methods, enhancing lymph node clearance and minimizing complications. The importance of surgeon experience and neoadjuvant treatment is discussed. ...
Neoadjuvant and Adjuvant Therapy for GEJ Cancers - Magnus Nilsson
ISDE Members Only
3views
0likes
Listen to Dr. Magnus Nilsson present during the ESDE Session on Gastro-Esophageal Junction (GEJ) Cancer Management held during the 2025 ISDE World Congress in Brisbane Australia from September 18-20, 2025. Watch all the presentations in this ...
Our Surgical Technique of Combined Resection with Aortic Adventitia Using Da Vinci Xi for Esophageal Cancer Invading Descending Aorta – Tomoki Makino
ISDE Members Only
2views
0likes
A 65-year-old male with lower esophageal adenocarcinoma classified as cT4b (invasion of the descending aorta) N2M0, cStageIVa, underwent six courses of chemotherapy (5FU+CDDP) combined with PD-1 antibody therapy at a previous institution. While ...
Multidisciplinary Tumour Board Case Discussions: Case 2
ISDE Members Only
2views
0likes
Listen to the panel discussion on Case 2 of the Multidisciplinary Tumour Board, moderated by Andrew Barbour and Ken Kato. The international panel of experts included: Medical oncology – Kei Muro, Victoria Atkinson Radiation oncology – Karin ...
Endoscopic Management of Strictures in EoE – Vivek Kaul
ISDE Members Only
1views
0likes
Listen to Dr. Vivek Kaul present during the Everything Eosinophilic Esophagitis: From Diagnosis to Treatment Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this ...
Nissen or Toupet: Is the Choice Still Needed? – Alia Qureshi
ISDE Members Only
5views
0likes
Listen to Dr. Alia Qureshi present during the AFS-ISDE Joint Session on What’s New with GERD?, held during the 2025 ISDE World Congress in Brisbane Australia from September 18-20, 2025. Watch all presentations in this session including: ...
Page 11 of 17